Good MorningEquity markets plunged on Thursday following hot inflation data. The September read of the Consumer Price Index came in hotter than expected at the headline and core levels as the cost of housing and wages continue to rise. The data seals the deal in regard to the Fed's next move which will be another 100 basis point interest rate hike according to the CMEs FedWatch Tool. If the next PCE Price Index reading is hot as well the FOMC could be forced to become even more aggressive. Technically speaking, the move hit a key support target at 3,500 which sparked a massive rebound that left the index up for the day.
Earnings season gets into high gear today with reports from the Big Banks. The banks are expected to show the benefit of rising interest rates but may scare the market if consumer and business banking results are weaker than expected. Rising interest rates help the spread upon which the banks make their money but also cut into economic activity. Featured: The “secret weapon” (Ad) 
|
Transportation | | A 4% jump in Delta’s (NYSE: DAL) shares on a day when the S&P 500 index sank to fresh lows is a good indication of what they might do over the next few months. The catalyst for the move higher was the company’s Q3 earnings report, which was released just before the bell rang to start... Read the Full Story |
|
From Our Partners | | We develop tools and strategies to the best of our ability, but we can't guarantee the future. There is always a risk of loss when trading. Past Performance is not indicative of future results. Between 10/30/23 - 4/2/2026, the win rate is 94.5%, the average return is 11.9% (including winners and losers), and the average hold time is less than 24 hours. | | Access the free day trading rules and criteria right now |
|
Technology | |
As interest rates rise, mortgage rates have climbed close to 7% over the past few months. This means that demand for housing has come down significantly. A number of factors, including the prevalence of working from home, has led many people to move away from metropolitan areas. Now that interest ... Read the Full Story |
|
Retail/Wholesale | |
Shares of Walgreens Boots Alliance (NYSE: WBA) are up more than 6% after the company posted a double beat in its fourth quarter earnings report. The company wrapped up its fiscal year with earnings per share (EPS) of 80 cents on revenue of $32.45 billion. That beat analysts’ expectations for... Read the Full Story |
|
From Our Partners | | Nvidia is up 203% this year. Microsoft, Amazon, Apple, and Alphabet have each surged between 36% and 62%. But one analyst believes the biggest AI winner hasn't been discovered yet.
He calls it the 'AI Wonder Stock' - a company with a market cap less than 1/1,000th of Microsoft's, still early-stage while the AI wave builds momentum. | | Watch the free presentation to see the AI Wonder Stock now |
|
Consumer Discretionary | |
Since its emergence as a “meme stock” in early 2021, AMC Entertainment (NYSE: AMC) has gone through bouts of short selling, short covering and just plain-old buying and selling.
Does continued short selling in AMC mean investors could see a bounce due to covering or a short squeeze? ... Read the Full Story |
|
Consumer Discretionary | | Casino operator MGM Resorts (NYSE: MGM) has been profitable during the post-pandemic recovery faring much better than leading rival casinos Las Vegas Sands (NYSE: LVS), Wynn Resorts (NASDAQ: WYNN), Melco (NASDAQ: MLCO). Ironically, its shares are down (-25%) lagging Las Vegas Sands stock trading up... Read the Full Story |
|
From Our Partners | | A top Wall Street adviser is warning of a new threat 62 times bigger than the Great Depression - one that Bloomberg says is already 'wreaking havoc' across the country.
It could wipe $33 trillion from the market and impact 67 million Americans. Major CEOs including Sam Altman are reportedly seeking help, and it has nothing to do with interest rates, the Fed, or geopolitical conflict. | | See what you can do right now to defend your portfolio |
|
Retail/Wholesale | |
If you are wondering why Domino’s Pizza (NYSE: DPZ) stock jumped nearly 10% on mixed news you’ve come to the right place. By the end of this article, you will understand what is driving this consumer giant's share price and where it may be headed next. The takeaways from the report inc... Read the Full Story |
|
Consumer Staples | |
Investors looking to ride out the current bear market may want to take a close look at Constellation Brands (NYSE:STZ). The company reported earnings on October 5 and beat on both the top and bottom lines.
In the first two quarters of Constellation’s 2023 fiscal year, it has generated yea... Read the Full Story |
|
Retail/Wholesale | | Car parts retailers O’Reilly Automotive (NASDAQ: ORLY) and AutoZone (NYSE: AZO) are both attempting to climb out of consolidations, as they outperform the broader market.
O’Reilly has been correcting since mid-August when it retreated from a high of $750.88. On a weekly chart, it&rsquo... Read the Full Story |
|
Medical | | The idea of a pill or injection to accelerate weight loss has been a holy grail since at least the 1800s, but could Amgen (NYSE: AMGN) be on the verge of a medical breakthrough?
The pharma company’s stock soared 5.72% Tuesday and was adding to those gains in Wednesday’s session.
Tuesd... Read the Full Story |
|
Consumer Staples | |
Nothing is more supportive of stock price over the long term than institutional buying. Institutions represent trillions of dollars of investible money and can produce strong tailwinds (or headwinds) for the market. The institutional tide has shifted due to the impacts of rising inflation, rising ... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy, an inheritable cardiac disorder; and BAG3 Dilated Cardiomyopathy. It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey. | | View Today's Stock Pick |
|
